Actionable news
All posts from Actionable news
Actionable news in OMER: Omeros Corporation,

Omeros Corporation just filed a prospectus, suggesting it plans to soon issue some securities

Omeros Corporation just came out with a new prospectus, available here. This is an SEC requirement for firms looking to issue certain types of securities. An excerpt of the prospectus is provided below:

The net proceeds that we receive from sales of our common stock pursuant to this prospectus supplement will depend on the number of shares actually sold and the offering price for such shares. There can be no assurance that we will be able to sell any shares under, or fully utilize, the Sales Agreement as a source of financing. Based on the closing price of our common stock on April 21, 2016 of $13.69, the maximum number of shares we could sell is 7,304,601. We estimate the offering expenses, other than the sales agents commissions, will be approximately $275,000. If we were to sell 7,304,601 shares of common stock at the April 21, 2016 closing price, we would receive $100.0 million in gross proceeds, which is approximately $98.0 million in net proceeds. The actual proceeds, if any, to us will vary.

We intend to use the net proceeds from sales under the Sales Agreement, if any, for general corporate purposes including expenses related to the continued commercialization of OMIDRIA, research and development expenses such as funding clinical trials, pre-clinical studies, manufacturing development and costs associated with otherwise advancing our drug candidates toward New Drug Application and Biologic License Application submissions. We may also use the net proceeds for working capital, the repayment of debt obligations, acquisitions or investments in businesses, products or technologies that are complementary to our own, and other capital expenditures. Our management will have broad discretion in the application of the net proceeds received from this offering, if any. Pending use of the net proceeds of this offering as described above, we intend to invest any net proceeds in short-term, investment-grade, interest-bearing instruments.


The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Omeros Corporation makes a similar move, sign up!

Other recent filings from the company include the following:

Omeros Corporation just filed a prospectus, suggesting it plans to soon issue some securities - April 22, 2016
Omeros Corporation releases salary data. CEO sees compensation fall -82% - April 22, 2016
Omeros Corporation's VP Patent and General Counsel just cashed-in 15,900 options - April 15, 2016